Trial intelligence / Profile preview

Placental Transfusion Hemodynamics in Premature Newborns

NCT04811872Phase 3Completed

Start
Jan 2021
Primary completion
Sep 2021
Countries
1
01

Overview

Phase 3, randomised, open-label trial (3 arms). Primary endpoints: Superior Vena Cava Flow at 3 days, Fractional Shortening at 3 days and 5 more. Started Jan 2021; status: completed.

Beyond the preview

Go deeper on NCT04811872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04811872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call